Obesity Medication Guidelines: Evidence-Based A...

By João L. Carapinha

January 15, 2026

Obesity Medication Guidelines: ADA's Evidence-Based Framework The American Diabetes Association (ADA) obesity medication guidelines, recently published, outline medications...
Equity-Based Pricing: Enhancing Value in Primary Care through Socioeconomic C...
EU Launches Joint Scientific Consultations to Enhance Health Technology Asses...
β-Blockers Myocardial Infarction: Reevaluating Their Role in Patients with Pr...
Epidyolex Spending in Portugal Exceeds €3 Million Amid Regulatory Delays
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
Johnson & Johnson’s Medicine Access Agreement: Paving the Way for ...
NHS Cost-Effectiveness Thresholds Boost Drug Approvals and Innovation
Driving Economic Transformation through Brain Health Investment in Africa
NICE Endorses Natalizumab RRMS Treatment Expansion for Refractory Cases
Bausch Health’s Strategic Growth in Latin American Pharmaceuticals Thro...
Johnson & Johnson’s EMA Application for Teclistamab Daratumumab Th...
Childhood Immunization Reforms: Aligning U.S. Schedules with Global Standards